An investigation into ACE2 as a molecular and genetic link to human coronary artery disease

ACE2 与人类冠状动脉疾病的分子和遗传联系的研究

• 批准号: nhmrc : GNT1132717
• 负责人: Dr Jay Ramchand
• 金额: $ 9.02万
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/an-investigation-ace2-artery-disease/1347854
• 关键词: investigation; into; ACE2; molecular; genetic

Coronary artery disease (CAD) is a leading cause of death but remains underdiagnosed so better tests are needed. We plan to perform a simple, new blood test in those with and without CAD. Our theory is that blood levels will be significantly increased only in those with CAD. If our theory is confirmed, this test may then be used to better predict those with CAD even before they develop symptoms. It will allow provision of early prevention strategies which will likely reduce complications of CAD.

冠状动脉疾病（CAD）是导致死亡的主要原因，但仍然诊断不足，因此需要更好的测试。我们计划在患有和没有CAD的人中进行简单的新血液测试。我们的理论是，血液水平将显着增加，只有在那些与CAD。如果我们的理论得到证实，那么这项测试可以用来更好地预测那些CAD患者，甚至在他们出现症状之前。它将允许提供可能减少CAD并发症的早期预防策略。